Health Canada has granted approval for the first generic version of the diabetes drug Ozempic, manufactured by Dr. Reddy’s Laboratories.This decision follows the expiration of the original patent held by Novo Nordisk and is expected to significantly reduce monthly costs for patients.Medical experts continue to emphasize that the medication must only be administered under the close supervision of healthcare professionals to ensure patient safety.